본문 바로가기
KERD
논문KCI 등재

국내 중증 급성 호흡기 증후군 코로나 바이러스의 검사실 내 진단: 현재, 한계점 그리고 직면한 과제

Laboratory Diagnosis of Coronavirus Disease 19 (COVID-19) in Korea: Current Status, Limitation, and Challenges

2

조회

0

다운로드

8

인용

0

참고문헌

키워드

주제분류기타자연과학

초록

2019년 12월, 중국 후베이성 우한시에서 COVID-19환자가처음으로 보고되었다. 그 이후 국내에서 신종 코로나 바이러스에 의해 야기된 중증 급성 호흡기 증후군 환자가 급격하게 증가하였다. 이러한 새로운 변종 바이러스는 기침, 인후통, 비루, 호흡곤란, 폐렴 및 기타 폐질환을 유발한다. 중증 급성 호흡기 증후군 코로나 바이러스 2는 RNA바이러스로, 실시간 역전사효소중합효소 연쇄반응을 통한 분자진단 검사가 COVID-19의 진단에 폭 넓게 사용되고 있다. 국내 질병관리본부와 식품의약품안전처의 긴급 사용 허가 승인에 따라, 건강한 사람과 COVID- 19 환자로부터 검체를 채취하여 진단검사의학적인 방법을 통해진단을 수행하고 있다. 기존에 출판된 많은 문헌 고찰을 통해, 본연구에서는 역학, 증상 및 질병관리본부의 승인을 받은 현재의검사실 내 COVID-19 분자 진단 방법, 분자 진단 검사와 혈청학적 진단의 차이, 임상 검체 가이드라인 등을 다시 한 번 확인하고자 하였다. 추가적으로 본 연구를 통해 국내 의료기관 내 의료종사자 및 임상병리사들의 병원 감염을 예방하고자 생물학적 안전에 관한 가이드라인을 확인하였다. 국내 임상병리사들의 경험과 그로부터 얻은 교훈을 통해 국내외 COVID-19 팬데믹 상황으로부터 국민의 안전을 지킬 수 있는 단초를 제공할 수 있을 것이라 사료된다.

Abstract

In December 2019, the first coronavirus disease- 2019 (COVID-19) patient was reported in Wuhan, Hubei Province, China. Since then, the number of patients who suffered severe acute respiratory syndrome caused by the novel Coronavirus (SARS-CoV-2 or 2019-nCoV) has increased dramatically in Korea. This new variant virus induces pulmonary diseases, including cough, sore throat, rhinorrhea, dyspnea, and pneumonia. Because SARS-CoV-2 is an RNA virus, real-time reversetranscriptase PCR has been used widely to diagnose COVID-19. As the Korea Centers for Disease Prevention and Control (KCDC) and Ministry of Food & Drug Safety (MFDS) approved emergency use authorization, clinical specimens collected from COVID-19 patients and even healthy people have been clinically diagnosed by laboratory medicine. Based on a literature search, this paper reviews the epidemiology, symptoms, molecular diagnostics approved by KCDC, a current diagnosis of COVID-19 in the laboratories, the difference between molecular and serological diagnosis, and guidelines for clinical specimens. In addition, the Korean guidelines of biosafety for clinical laboratory scientists are evaluated to prevent healthcare-associated infection. The author’s experience and lessons as clinical laboratory scientists will provide valuable insights to protect the domestic and international health community in this COVID-19 pandemic around the world.

참고문헌 (38)

  1. King AMQ, "Family - Coronaviridae", pp.806~828 (2012), Elsevier
  2. Shuo Su, "Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses", Trends in Microbiology, 24(6), pp.490~502 (2016), Elsevier BV[DOI]
  3. Terho Heikkinen, "The common cold", The Lancet, 361(9351), pp.51~59 (2003), Elsevier BV[DOI]
  4. "Cumulative number of reported probable cases of SARS" (2020)[URL]
  5. Christian Drosten, "Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome", New England Journal of Medicine, 348(20), pp.1967~1976 (2003), Massachusetts Medical Society[DOI]
  6. NS Zhong, "Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003", The Lancet, 362(9393), pp.1353~1358 (2003), Elsevier BV[DOI]
  7. Ali M. Zaki, "Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia", New England Journal of Medicine, 367(19), pp.1814~1820 (2012), Massachusetts Medical Society[DOI]
  8. "MERS situation update, January 2020" (2020)[URL]
  9. Na Zhu, "A Novel Coronavirus from Patients with Pneumonia in China, 2019", New England Journal of Medicine, 382(8), pp.727~733 (2020), Massachusetts Medical Society[DOI]
  10. Gorbalenya AE, "The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2", Nature Microbiology, 5(4), pp.536~544 (2020), Springer Science and Business Media LLC[DOI]
  11. "WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020" (2020)[URL]
  12. Jeong-Min Kim, "Identification of Coronavirus Isolated from a Patient in Korea with COVID-19", Osong Public Health and Research Perspectives, 11(1), pp.3~7 (2020), 질병관리청[DOI]
  13. Ensheng Dong, "An interactive web-based dashboard to track COVID-19 in real time", The Lancet Infectious Diseases, 20(5), pp.533~534 (2020), Elsevier BV[DOI]
  14. Chen Wang, "A novel coronavirus outbreak of global health concern", The Lancet, 395(10223), pp.470~473 (2020), Elsevier BV[DOI]
  15. "COVID-19 confirmed patient status" (2020)[URL]
  16. "18 Feb 2020 COVID-19 status" (2020)[URL]
  17. "Korea, Domestic status of COVID-19, 20 Apr" (2020)[URL]
  18. 기모란, "Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea", Epidemiology and Health, 42, pp.1~7 (2020), 한국역학회[DOI]
  19. Dawei Wang, "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China", JAMA, 323(11), pp.1061~1069 (2020), American Medical Association (AMA)[DOI]
  20. Jin Yong Kim, "The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures", Journal of Korean Medical Science, 35(5), pp.1~4 (2020), 대한의학회[DOI]
  21. Eu Suk Kim, "Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19", Journal of Korean Medical Science, 35(13), pp.1~12 (2020), 대한의학회[DOI]
  22. Peong Gang Park, "Out-of-Hospital Cohort Treatment of Coronavirus Disease 2019 Patients with Mild Symptoms in Korea: an Experience from a Single Community Treatment Center", Journal of Korean Medical Science, 35(13), pp.1~6 (2020), 대한의학회[DOI]
  23. Guangming Ye, "Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation", Journal of Infection, 80(5), pp.e14~e17 (2020), Elsevier BV[DOI]
  24. 안대균, "Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)", Journal of Microbiology and Biotechnology, 30(3), pp.313~324 (2020), 한국미생물·생명공학회
  25. "Laboratory testing for coronavirus disease (COVID-19)in suspected human cases: interim guidance, 19 March 2020" (2020)[URL]
  26. Victor M Corman, "Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR", Eurosurveillance, 25(3), pp.2000045~ (2020), European Centre for Disease Control and Prevention (ECDC)[DOI]
  27. Ki Ho Hong, "Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea", Annals of Laboratory Medicine, 40(5), pp.351~360 (2020), 대한진단검사의학회[DOI]
  28. "Product information of emergency use authorizations for COVID-19 genetic detection tests" (2020)[URL]
  29. "Guidelines for the laboratory diagnosis of COVID-19 in Korea" (2020)[URL]
  30. "COVID-19 response guidelines" (2020)[URL]
  31. Xiong Wang, "Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously", International Journal of Infectious Diseases, 94, pp.107~109 (2020), Elsevier BV[DOI]
  32. Michael J. Loeffelholz, "Laboratory diagnosis of emerging human coronavirus infections – the state of the art", Emerging Microbes & Infections, 9(1), pp.747~756 (2020), Informa UK Limited[DOI]
  33. Zhengtu Li, "Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis", Journal of Medical Virology, 92(9), pp.1518~1524 (2020), Wiley[DOI]
  34. Sandeep Kumar Vashist, "In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends", Diagnostics, 10(4), pp.202~ (2020), MDPI AG[DOI]
  35. Wenling Wang, "Detection of SARS-CoV-2 in Different Types of Clinical Specimens", JAMA, 323, pp.1843~1844 (2020), American Medical Association (AMA)[DOI]
  36. Wei Zhang, "Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes", Emerging Microbes & Infections, 9(1), pp.386~389 (2020), Informa UK Limited[DOI]
  37. Iwen PC, "Safety considerations in the laboratory testing of specimens suspected or known to contain the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)", Am J Clin Pathol, 153, pp.567~570 (2020)[DOI]
  38. Zhiruo Zhang, "Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions", Frontiers of Medicine, 14(2), pp.229~231 (2020), Springer Science and Business Media LLC[DOI]

관련 논문AI추천

코로나19 판데믹 사태에서 대한진단검사의학회의 초기 대응 현황고대현, 권계철, 김영은, 노경호, 박형두, 윤승규, 이재현, 조진희, 지미숙, 홍기호대한진단검사의학회 · Laboratory Medicine Online2021 · 제11권 제4호Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea성문우, Cheon Kwon Yoo, Gab Jung Kim, Hee Jae Huh, Heungsup Sung, Hyukmin Lee, Hyun Soo Kim, Jaehyeon Lee, Jae-Seok Kim, Jae-Sun Park, Ki Ho Hong, Kye-Chul Kwon, Kyoung Ho Roh, Namhee Ryoo, Sang Won Lee, Seung-Tae Lee, So Yeon Kim, Taek Soo Kim대한진단검사의학회 · Annals of Laboratory Medicine2020 · 제40권 제5호Current laboratory diagnosis of coronavirus disease 2019Jehoon Lee, Jihyang Lim대한내과학회 · The Korean Journal of Internal Medicine2020 · 제35권 제4호코로나바이러스감염증-19(COVID-19) 진단을 위한 검사실 검사김재석, 김현수, 성흥섭, 이혁민, 홍기호한국보건의료기술평가학회 · 보건의료기술평가2020 · 제8권 제1호COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays성문우, Cheon Kwon Yoo, Heungsup Sung, Hyukmin Lee, Hyun Soo Kim, Jaehyeon Lee, Ki Ho Hong, Kyoung Ho Roh, Mi-Na Kim, Myung-Guk Han, Namhee Ryoo, Sang Won Lee, Sookwon Yoo, So Yeon Kim대한진단검사의학회 · Annals of Laboratory Medicine2020 · 제40권 제6호COVID-19 대유행이 있었던 대구의 한 대학병원 진단검사의학과에서의 경험김도훈, 류남희, 박성균, 이원목, 이재희, 전동석, 하정숙대한임상미생물학회 · Annals of Clinical Microbiology2020 · 제23권 제4호

이 간행물의 다른 논문 (15건)